Healthcare Services

Drug discovery technologies market analysis with key growth drivers and outlook

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Drug Discovery Technologies Market During 2026–2030?

The drug discovery technologies market size has experienced significant expansion in recent years. This market is expected to grow from $80.76 billion in 2025 to $90.23 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.7%. The historical growth of this market can be attributed to several factors including screening automation development, genomic research expansion, computational chemistry adoption, biologics research growth, and drug pipeline complexity.

The drug discovery technologies market size is set to observe significant expansion in the coming years. It is forecasted to escalate to $138.44 billion in 2030, achieving a compound annual growth rate (CAGR) of 11.3%. This upward trajectory in the forecast period is fueled by elements such as AI-driven molecular design, a strong emphasis on personalized medicine, the integration of advanced analytics, the development of novel therapeutic modalities, and accelerated discovery timelines. Prominent trends throughout the forecast period include the increasing uptake of high throughput screening, a rise in the use of bioinformatics platforms, the broadening scope of RNA-based drug discovery, the growing application of nanotechnology in drug design, and the integration of pharmacogenomics in discovery processes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

What Key Drivers Are Fueling The Growth Of The Drug Discovery Technologies Market?

The future expansion of the drug discovery technologies market is expected to be propelled by rising healthcare expenditures. Healthcare expenditures refer to the complete financial resources allocated for medical services, public health initiatives, family planning, nutritional programs, and emergency health support. Healthcare spending continues to increase due to factors such as growing demand for advanced treatments, an aging populace, the burden of chronic diseases, and broader access to healthcare services. The drug discovery technologies industry capitalizes on this trend by utilizing increased funding to enhance research platforms, analytical tools, and digital technologies, thereby accelerating therapeutic innovation. For instance, in May 2024, the Office of National Statistics, a UK-based government agency, reported that total healthcare expenditure grew by 5.6% in nominal terms between 2022 and 2023, which is a significant rise compared to the 0.9% growth observed in 2022. Therefore, the increase in healthcare expenditures is fueling the growth of the drug discovery technologies market.

Which Segments Define The Drug Discovery Technologies Market Segment Structure?

The drug discovery technologies market covered in this report is segmented –

1) By Technology: High Throughput Screening, Genomics, Nanotechnology, Bioinformatics, Combinational Chemistry, Pharmacogenomics, Biochips, Bioanalytical Instruments, Ribonucleic Acid Interface (RNAI)

2) By Drug Type: Small Molecule Drugs, Biologic Drugs

3) By Disease Application: Cancer Diseases, Immunological Diseases, Neurological Diseases, Cardiovascular Diseases, Other Disease Applications

4) By End-User: Pharmaceutical Companies, Biopharmaceutical Companies, Biotechnology Companies, Research Institutes, Other End-Users

Subsegments:

1) By High Throughput Screening: Automated Screening Systems, Assay Development

2) By Genomics: DNA Sequencing, Genomic Data Analysis

3) By Nanotechnology: Nanoparticle-Based Drug Delivery, Nanomaterials For Drug Formulation

4) By Bioinformatics: Data Analysis Tools, Computational Biology Software

5) By Combinational Chemistry: Library Synthesis Techniques, Screening Methods

6) By Pharmacogenomics: Genetic Testing Platforms, Personalized Medicine Applications

7) By Biochips: Microarrays, Lab-On-A-Chip Technologies

8) By Bioanalytical Instruments: Mass Spectrometry, Chromatography Systems

9) By Ribonucleic Acid Interface (RNAI): RNA Interference Technologies, Therapeutic RNA Applications

What Trends Are Influencing The Drug Discovery Technologies Market?

Major companies within the drug discovery technologies market are prioritizing the development of sophisticated solutions, such as drug research and development platforms, to enhance precision, boost high-throughput analysis, and accelerate the identification of novel therapeutic compounds. A drug research and development platform serves as an integrated framework that streamlines the processes of finding, designing, optimizing, and validating pharmaceutical candidates through cohesive workflows and data-driven tools. As an illustration, in July 2023, Dotmatics Inc., a US-based scientific software company, introduced the Small Molecule Drug Discovery Solution. This comprehensive R&D platform features pre-configured workflows and improved data management capabilities designed to promote collaboration, elevate productivity, and simplify operations. This platform empowers researchers to efficiently convert data into actionable insights and supports a unified workspace from initial hit discovery through lead optimization, thereby speeding up the creation of life-enhancing drug therapies.

Who Are The Established Players Within The Drug Discovery Technologies Market?

Major companies operating in the drug discovery technologies market are F. Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Merck KGaA, GE HealthCare Technologies Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Evotec SE, Curia Global Inc., Aragen Life Sciences Private Limited, Luminex Corporation, BioXcel Therapeutics Inc., Certara Inc., Schrödinger Inc., Sygnature Discovery Ltd., Recursion Pharmaceuticals Inc., InSilico Medicine Inc., ChemAxon Ltd., Enamine Ltd., BenevolentAI Limited, OpenEye Scientific Software Inc., Collaborative Drug Discovery Inc., Pharmacelera S.L., Gyros Protein Technologies AB, Optibrium Ltd., Cresset Group, Relay Therapeutics Inc.

Get The Full Drug Discovery Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Which Region Is The Top Contributor To The Drug Discovery Technologies Market By Share?

North America was the largest region in the drug discovery technologies market in 2025. The regions covered in the drug discovery technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drug Discovery Technologies Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Browse Through More Reports Similar to the Global Drug Discovery Technologies Market 2026, By The Business Research Company

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Informatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795